Information on the target
Fagron BV has successfully acquired a 100% stake in SB Trade d.o.o., a Belgrade-based company established in 1993. SB Trade specializes in the supply of raw materials for individual use and the production of cosmetics, catering to a diverse clientele. This acquisition aligns with Fagron's commitment to enhancing its portfolio in the life sciences sector, particularly in personalized medicine.
With operations spanning 35 countries globally, Fagron focuses on delivering tailored pharmaceutical solutions to hospitals, pharmacies, clinics, and patients. The integration of SB Trade's capabilities is expected to bolster Fagron's offerings and expand its market reach in the cosmetics and raw materials segment.
Industry overview in the target’s specific country
The life sciences industry in Serbia has been experiencing significant growth, driven by increased demand for personalized healthcare solutions and advancements in biotechnology. The Serbian market is characterized by a strong emphasis on research and development, with numerous local companies emerging as key players in the production of pharmaceuticals and cosmetics.
Serbia's strategic location in Southeast Europe provides a competitive advantage for companies operating in the life sciences sector. The country benefits from a skilled workforce, favorable regulatory environment, and access to both European and global markets. This has attracted foreign investments and fostered collaborations between local firms and international partners.
Moreover, the Serbian government has been actively promoting the life sciences industry through various initiatives aimed at enhancing innovation and supporting startups. This supportive ecosystem is conducive to the growth of companies like SB Trade, which are well-positioned to capitalize on the increasing demand for high-quality raw materials and personalized products.
The rationale behind the deal The acquisition of SB Trade d.o.o. by Fagron BV is a strategic move aimed at strengthening Fagron's position in the life sciences market. By integrating SB Trade's expertise in raw materials a…